Guilin Layn Natural Ingredients Corp. (002166.SZ): Termination of agreement on transfer of controlling shareholder and change of control rights.

date
20:45 22/06/2026
avatar
GMT Eight
Rein Biotech (002166.SZ) announced that, due to changes in the external market environment and the failure to meet trading conditions, after careful consideration and friendly negotiations, the controlling shareholder and actual controller of the company, Qin Benjun, signed a termination agreement with Guangzhou Defu Nutrition Investment Partnership Enterprise (Limited Partnership) (referred to as "Guangzhou Defu Nutrition") on June 22, 2026, agreeing to terminate the transfer of equity agreement and related matters concerning the termination of control rights transfer.
Guilin Layn Natural Ingredients Corp. (002166.SZ) has announced that due to changes in the external market environment and the failure to achieve trading conditions, after careful consideration and friendly negotiations, the company's controlling shareholder and actual controller Qin Benjun and Guangzhou Defu Nutrition Investment Partnership Enterprise (Limited Partnership) (referred to as "Guangzhou Defu Nutrition") signed a termination agreement on June 22, 2026, agreeing to terminate the share transfer agreement and related matters regarding the termination of control rights changes. The original agreement stated that Qin Benjun would transfer 60 million shares (8.09% of the company's total share capital) to Guangzhou Defu Nutrition and waive the voting rights of 189 million shares (25.50% of the company's total share capital). The shares transferred under the original agreement have not been registered for transfer, so the amount of shares held by all parties has not changed, and therefore the company's controlling shareholder and actual controller have not actually changed.